COI
ABBV icon

Capital One Investing’s AbbVie ABBV Stock Holding History

Capital One Investing’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$734K Sell
9,700
-1,582
-14% -$108K 0.17% 94
2019
Q2 		$820K Buy
11,282
+1,300
+13% +$102K 0.2% 80
2019
Q1 		$805K Buy
+9,982
New +$817K 0.21% 78

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital One Investing's ABBV Position: Q3 2019 in Review

Capital One Investing reduced its AbbVie (ABBV) stake by 14% in Q3 2019, selling an estimated $108K and leaving 9,700 shares worth $734K. The position accounts for 0.17% of the portfolio, ranked #94.

Capital One Investing first reported a position in ABBV in Q1 2019 and has held it in 3 quarters since. The position peaked at $820K in Q2 2019. 2,003 funds tracked by Wall St. Rank hold ABBV as of Q3 2019.

  • Capital One Investing held 9,700 shares of AbbVie worth $734K as of Q3 2019.
  • Capital One Investing sold 1,582 AbbVie shares in Q3 2019, an estimated $108K.
  • AbbVie made up 0.17% of Capital One Investing's portfolio in Q3 2019, its #94 holding.
  • Capital One Investing first reported a position in AbbVie in Q1 2019 and has held it in 3 quarters since.
  • Capital One Investing's AbbVie position peaked at $820K in Q2 2019.
  • 2,003 funds tracked by Wall St. Rank held AbbVie as of Q3 2019.

Based on Capital One Investing's 13F filing for Q3 2019, filed 14 Nov 2019.